Ferrajoli, A <br/><br/>
The JAK-STAT pathway: a therapeutic target in hematological malignancies.  [electronic resource] 

 -  Current cancer drug targets  Dec 2006 
 - 671-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Standard No.: </label>10.2174/156800906779010227  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Hematologic Neoplasms--drug therapy<br/>Histone Deacetylase Inhibitors<br/>Humans<br/>Janus Kinases--antagonists & inhibitors<br/>PPAR gamma--agonists<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>STAT Transcription Factors--antagonists & inhibitors<br/>Signal Transduction--drug effects